Last10K.com

Intellipharmaceutics International Inc. (IPCI) SEC Filing 20-F Annual report for the fiscal year ending Monday, November 30, 2009

Intellipharmaceutics International Inc.

CIK: 1474835 Ticker: IPCI

View differences made from one year to another to evaluate Intellipharmaceutics International Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Intellipharmaceutics International Inc..

Continue

Assess how Intellipharmaceutics International Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Intellipharmaceutics International Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue